An anti-allergy, anti-asthma and anti-diabetic agent. Improves obesity-related metabolic dysfunction in mouse models. Increases thermogenesis and weight loss, decreases steatosis and improves insulin sensitivity. Inhibits TANK-binding kinase 1 (TBK1) and IKKe (IC50 =1.2 μM). Clinically useful in treatment of aphthus ulcers. MW: 298.29. Purity ≥98% by TLC
Size
10 mg
Concentration
n/a
Applications
n/a
Other Names
2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ; AA 673; Amoxanox, CHX 3673